OPTIMIZING EXISTING TOOLS FOR REACHING AN ADEQUATE DISEASE CONTROL IN PATIENTS WITH SPONDYLOARTHRITIS
Background/Objective. Disease activity in spondyloarthritis (SpA) is evaluated through conventional scores such as BASDAI or ASDAS. The aim of this study was to determine disease activity in SpA patients under biological therapy with further assessment on the quality of each activity indicator and t...
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Amaltea Medical Publishing House
2016-06-01
|
| Series: | Romanian Journal of Rheumatology |
| Subjects: | |
| Online Access: | https://rjr.com.ro/articles/2016.2/RJR_2016_2_Art-05.pdf |
| _version_ | 1819143684432592896 |
|---|---|
| author | Claudia Deaconu Daniela Opris Diana Mazilu Laura Groseanu Andreea Borangiu Saulescu Ioana Alexandra Peltea Magdalena Negru Cosmin Constantinescu Violeta Vlad Violeta Bojinca Andra Balanescu Denisa Predeteanu Ruxandra Ionescu |
| author_facet | Claudia Deaconu Daniela Opris Diana Mazilu Laura Groseanu Andreea Borangiu Saulescu Ioana Alexandra Peltea Magdalena Negru Cosmin Constantinescu Violeta Vlad Violeta Bojinca Andra Balanescu Denisa Predeteanu Ruxandra Ionescu |
| author_sort | Claudia Deaconu |
| collection | DOAJ |
| description | Background/Objective. Disease activity in spondyloarthritis (SpA) is evaluated through conventional scores such as BASDAI or ASDAS. The aim of this study was to determine disease activity in SpA patients under biological therapy with further assessment on the quality of each activity indicator and their clinical value together with their impact on NSAID intake.
Materials and methods. Over nine months (January–August 2015) we enrolled 100 patients with SpA on anti-TNF therapy (33% IFX; 35% ADL; 32% ETA). We collected demographic, clinical (BASDAI, ASDAS, PtGA) and laboratory data (ESR, CRP). Frequency of NSAID ingestion expressed as days per week was included in a questionnaire. Considering their biologic treatment, patients were divided into disease activity groups and sample characteristics were correlated and compared. Statistical analysis was performed with SPSS 20.0, using specific tests such as Pearson, Spearman or ANOVA.
Results. Patients with active disease, stated by both activity scores had an increased NSAID intake. Out of 86% of patients with a BASDAI under 4, only 82.6% had an ASDAS-CRP lower than 1.3. BASDAI correlated to both ASDAS scores (r = 0.65 and 0.71, P<0.001) and PtGA correlated to both disease activity scales, with a stronger correlation to BASDAI (r = 0.912, P<0.01) than ASDAS (r = 0.67 and 0.71, P<0.01 for both).
Conclusion. We proved that disease activity scores have good discriminatory power, with a strong correlation between the subjective BASDAI and PtGA. However, ASDAS-CRP proves to be more rigorous than other variables when targeting high and low disease activity, thus indicating the need of an objective component in assessing these patients. |
| first_indexed | 2024-12-22T12:30:09Z |
| format | Article |
| id | doaj.art-766a60ce68cc4d658442c7c09df4c94a |
| institution | Directory Open Access Journal |
| issn | 1843-0791 2069-6086 |
| language | English |
| last_indexed | 2024-12-22T12:30:09Z |
| publishDate | 2016-06-01 |
| publisher | Amaltea Medical Publishing House |
| record_format | Article |
| series | Romanian Journal of Rheumatology |
| spelling | doaj.art-766a60ce68cc4d658442c7c09df4c94a2022-12-21T18:25:41ZengAmaltea Medical Publishing HouseRomanian Journal of Rheumatology1843-07912069-60862016-06-01252889410.37897/RJR.2016.2.5OPTIMIZING EXISTING TOOLS FOR REACHING AN ADEQUATE DISEASE CONTROL IN PATIENTS WITH SPONDYLOARTHRITISClaudia Deaconu0Daniela Opris1Diana Mazilu2Laura Groseanu3Andreea Borangiu4Saulescu Ioana5Alexandra Peltea6Magdalena Negru7Cosmin Constantinescu8Violeta Vlad9Violeta Bojinca10Andra Balanescu11Denisa Predeteanu12Ruxandra Ionescu13Department of Rheumatology and Internal Medicine, Sfanta Maria Clinical Hospital Bucharest, RomaniaDepartment of Rheumatology and Internal Medicine, Sfanta Maria Clinical Hospital Bucharest, Romania; Carol Davila University of Medicine and Pharmacy, Bucharest, RomaniaDepartment of Rheumatology and Internal Medicine, Sfanta Maria Clinical Hospital Bucharest, Romania; Carol Davila University of Medicine and Pharmacy, Bucharest, RomaniaDepartment of Rheumatology and Internal Medicine, Sfanta Maria Clinical Hospital Bucharest, Romania; Carol Davila University of Medicine and Pharmacy, Bucharest, RomaniaDepartment of Rheumatology and Internal Medicine, Sfanta Maria Clinical Hospital Bucharest, Romania; Carol Davila University of Medicine and Pharmacy, Bucharest, RomaniaDepartment of Rheumatology and Internal Medicine, Sfanta Maria Clinical Hospital Bucharest, Romania; Carol Davila University of Medicine and Pharmacy, Bucharest, RomaniaDepartment of Rheumatology and Internal Medicine, Sfanta Maria Clinical Hospital Bucharest, RomaniaDepartment of Rheumatology and Internal Medicine, Sfanta Maria Clinical Hospital Bucharest, Romania; Carol Davila University of Medicine and Pharmacy, Bucharest, RomaniaDepartment of Rheumatology and Internal Medicine, Sfanta Maria Clinical Hospital Bucharest, Romania; Carol Davila University of Medicine and Pharmacy, Bucharest, RomaniaDepartment of Rheumatology and Internal Medicine, Sfanta Maria Clinical Hospital Bucharest, RomaniaDepartment of Rheumatology and Internal Medicine, Sfanta Maria Clinical Hospital Bucharest, Romania; Carol Davila University of Medicine and Pharmacy, Bucharest, RomaniaDepartment of Rheumatology and Internal Medicine, Sfanta Maria Clinical Hospital Bucharest, Romania; Carol Davila University of Medicine and Pharmacy, Bucharest, RomaniaDepartment of Rheumatology and Internal Medicine, Sfanta Maria Clinical Hospital Bucharest, Romania; Carol Davila University of Medicine and Pharmacy, Bucharest, RomaniaDepartment of Rheumatology and Internal Medicine, Sfanta Maria Clinical Hospital Bucharest, Romania; Carol Davila University of Medicine and Pharmacy, Bucharest, RomaniaBackground/Objective. Disease activity in spondyloarthritis (SpA) is evaluated through conventional scores such as BASDAI or ASDAS. The aim of this study was to determine disease activity in SpA patients under biological therapy with further assessment on the quality of each activity indicator and their clinical value together with their impact on NSAID intake. Materials and methods. Over nine months (January–August 2015) we enrolled 100 patients with SpA on anti-TNF therapy (33% IFX; 35% ADL; 32% ETA). We collected demographic, clinical (BASDAI, ASDAS, PtGA) and laboratory data (ESR, CRP). Frequency of NSAID ingestion expressed as days per week was included in a questionnaire. Considering their biologic treatment, patients were divided into disease activity groups and sample characteristics were correlated and compared. Statistical analysis was performed with SPSS 20.0, using specific tests such as Pearson, Spearman or ANOVA. Results. Patients with active disease, stated by both activity scores had an increased NSAID intake. Out of 86% of patients with a BASDAI under 4, only 82.6% had an ASDAS-CRP lower than 1.3. BASDAI correlated to both ASDAS scores (r = 0.65 and 0.71, P<0.001) and PtGA correlated to both disease activity scales, with a stronger correlation to BASDAI (r = 0.912, P<0.01) than ASDAS (r = 0.67 and 0.71, P<0.01 for both). Conclusion. We proved that disease activity scores have good discriminatory power, with a strong correlation between the subjective BASDAI and PtGA. However, ASDAS-CRP proves to be more rigorous than other variables when targeting high and low disease activity, thus indicating the need of an objective component in assessing these patients.https://rjr.com.ro/articles/2016.2/RJR_2016_2_Art-05.pdfspondyloarthritisdisease activity scoresdiscriminatory poweranti-tnf therapy |
| spellingShingle | Claudia Deaconu Daniela Opris Diana Mazilu Laura Groseanu Andreea Borangiu Saulescu Ioana Alexandra Peltea Magdalena Negru Cosmin Constantinescu Violeta Vlad Violeta Bojinca Andra Balanescu Denisa Predeteanu Ruxandra Ionescu OPTIMIZING EXISTING TOOLS FOR REACHING AN ADEQUATE DISEASE CONTROL IN PATIENTS WITH SPONDYLOARTHRITIS Romanian Journal of Rheumatology spondyloarthritis disease activity scores discriminatory power anti-tnf therapy |
| title | OPTIMIZING EXISTING TOOLS FOR REACHING AN ADEQUATE DISEASE CONTROL IN PATIENTS WITH SPONDYLOARTHRITIS |
| title_full | OPTIMIZING EXISTING TOOLS FOR REACHING AN ADEQUATE DISEASE CONTROL IN PATIENTS WITH SPONDYLOARTHRITIS |
| title_fullStr | OPTIMIZING EXISTING TOOLS FOR REACHING AN ADEQUATE DISEASE CONTROL IN PATIENTS WITH SPONDYLOARTHRITIS |
| title_full_unstemmed | OPTIMIZING EXISTING TOOLS FOR REACHING AN ADEQUATE DISEASE CONTROL IN PATIENTS WITH SPONDYLOARTHRITIS |
| title_short | OPTIMIZING EXISTING TOOLS FOR REACHING AN ADEQUATE DISEASE CONTROL IN PATIENTS WITH SPONDYLOARTHRITIS |
| title_sort | optimizing existing tools for reaching an adequate disease control in patients with spondyloarthritis |
| topic | spondyloarthritis disease activity scores discriminatory power anti-tnf therapy |
| url | https://rjr.com.ro/articles/2016.2/RJR_2016_2_Art-05.pdf |
| work_keys_str_mv | AT claudiadeaconu optimizingexistingtoolsforreachinganadequatediseasecontrolinpatientswithspondyloarthritis AT danielaopris optimizingexistingtoolsforreachinganadequatediseasecontrolinpatientswithspondyloarthritis AT dianamazilu optimizingexistingtoolsforreachinganadequatediseasecontrolinpatientswithspondyloarthritis AT lauragroseanu optimizingexistingtoolsforreachinganadequatediseasecontrolinpatientswithspondyloarthritis AT andreeaborangiu optimizingexistingtoolsforreachinganadequatediseasecontrolinpatientswithspondyloarthritis AT saulescuioana optimizingexistingtoolsforreachinganadequatediseasecontrolinpatientswithspondyloarthritis AT alexandrapeltea optimizingexistingtoolsforreachinganadequatediseasecontrolinpatientswithspondyloarthritis AT magdalenanegru optimizingexistingtoolsforreachinganadequatediseasecontrolinpatientswithspondyloarthritis AT cosminconstantinescu optimizingexistingtoolsforreachinganadequatediseasecontrolinpatientswithspondyloarthritis AT violetavlad optimizingexistingtoolsforreachinganadequatediseasecontrolinpatientswithspondyloarthritis AT violetabojinca optimizingexistingtoolsforreachinganadequatediseasecontrolinpatientswithspondyloarthritis AT andrabalanescu optimizingexistingtoolsforreachinganadequatediseasecontrolinpatientswithspondyloarthritis AT denisapredeteanu optimizingexistingtoolsforreachinganadequatediseasecontrolinpatientswithspondyloarthritis AT ruxandraionescu optimizingexistingtoolsforreachinganadequatediseasecontrolinpatientswithspondyloarthritis |